Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesPayablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Quantumzyme (QTZM) Long-Term Deferred Tax (2025)

Quantumzyme (QTZM) has 2 years of Long-Term Deferred Tax data on record, last reported at $1.2 million in Q3 2025.

  • For Q3 2025, Long-Term Deferred Tax rose 3.66% year-over-year to $1.2 million; the TTM value through Jul 2025 reached $1.2 million, up 3.66%, while the annual FY2025 figure was $1.2 million, 3.66% up from the prior year.
  • Long-Term Deferred Tax reached $1.2 million in Q3 2025 per QTZM's latest filing, up from $1.1 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $1.2 million in Q3 2025 and bottomed at $1.1 million in Q3 2024.